A Multikilogram-Scale Synthesis
of (R)-Methyl 2-[(1r,4R)-4-(tert-Butoxycarbonylamino)cyclohexyl]-2-(2-nitrophenylsulfonamido)acetate - A
Doubly Protected Building Block with Three Points of Variation
Gregory Carr*a, Sam Butterwortha, Phil Walkera, Folkert Reckb, Bolin Gengb, Lakshmipathi Pandarinathanb a Astrazeneca Pharmaceuticals, Alderley
Park, Macclesfield, Cheshire, SK10 4TG, UK b Infection Innovative Medicines Unit, AstraZeneca R & D Boston, 35
Gatehouse Drive, Waltham, MA 02451, USA Fax: +44(1625)513910; e-Mail: greg.carr@astrazeneca.com;